<DOC>
	<DOCNO>NCT02489487</DOCNO>
	<brief_summary>A randomized single dose , drug-drug interaction study healthy volunteer VM - 1500 give alone combination Raltegravir Darunavir 3 arm approach . The parallel design use due long half life VM-1500 .</brief_summary>
	<brief_title>Study Healthy Volunteers Investigate Safety , Tolerability Pharmacokinetics VM-1500</brief_title>
	<detailed_description>This drug-drug interaction study do cross-over study due extreme long half life drug . The 24 healthy subject participate randomized VM-1500 alone VM-1500 combination Raltegravir Darunavir parallel arm . For cohort take VM-1500 40 mg 4 subject enrol 6 subject already regimen trial . Based parallel design seem appropriate expose healthy subject necessary . This mean available data 6 subject dose 40 mg VM-1500 alone match . Three group healthy subject randomize VM-1500 alone VM-1500 combination Raltegravir Darunavir ( 4:10:10 ) . The healthy subject stay unit receive 40 mg VM-1500 alone VM1500 combination Raltegravir Darunavir one time PK blood sample several time point collect . PK ( trough level ) blood sample also collect visit Days 2 , 4,7 , 14 , 21 , Day 36 .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Darunavir</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>1 . Male subject age 1845 year 2 . Has determine healthy physical examination , assessment drug abuse , medical history vital sign 3 . Has normal acceptable result follow screening test : complete blood count ( CBC ) , blood urea nitrogen ( BUN ) , serum creatinine ( Cr ) , fast blood sugar ( FBS ) , total bilirubin , aspartate aminotransferase ( AST SGOT ) , alanine aminotransferase ( ALT SGPT ) , alkaline phosphatase ( ALP ) urinalysis . 4 . Negative result hepatitis A , hepatitis B , hepatitis C HIV antibodies 5 . Willing participate sign informed consent form 1 . Hepatic kidney disorder disease disorder may opinion Investigator interfere result study threaten health volunteer ; 2 . Drug intake ( include herbal drug ) last month ; 3 . Active alcohol and/or drug abuse , opinion site investigator , would interfere adherence study requirement ; 4 . Volunteers take investigational drug least 3 month prior start study ; 5 . Inability understand Protocol follow instruction .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>